Selection and uses of lactic acid bacteria strains modulating non-specific immunity
US7183108B1 · kind B1 · utility
1Cited by
6References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 1999 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Nov 18, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/177692
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said enterocytes. The strains can also be incorporated in food supplements such as fermented dairy products used for regulating inflammatory response and non-specific immunity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.